AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the Top 10 Hot Stocks with the Highest Upside Potential. On June 5, AbCellera Biologics Inc. (NASDAQ:ABCL) reported that it has appointed Dr. Victor ...

The biomedical company announced plans on Monday to bring 1,200 jobs and relocate 300 jobs from Charlotte to Rock Hill.

NetworkNewsAudio announces the Audio Press Release (APR) titled “Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis,” featuring Quantum BioPharma Ltd.

AbCellera has announced the appointment of Victor Sandor, M.D. C.M, to its Board of Directors as an independent director.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one ...

The shape of that competition is given physical form at the 2026 BIO International Convention (BIO 2026) in San Diego, ...

Now, Quantum BioPharma Ltd. is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly ...

Ambrosia Biosciences Inc., named after the drink of the Greek gods, secured a $100 million series B to advance its preclinical pipeline of oral obesity drugs. The startup formed after Pfizer Inc.

Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the past 10 years. IQVIA shared the data in a report that tracked surges in ...

March 24 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab said on Tuesday it has approved a U.S. initial ‌public offering of its U.S. biopharma business. Grifols, which makes drugs using ...